Literature DB >> 21480188

C8orf13-BLK is a genetic risk locus for systemic sclerosis and has additive effects with BANK1: results from a large french cohort and meta-analysis.

Baptiste Coustet1, Philippe Dieudé, Mickael Guedj, Mathieu Bouaziz, Jerome Avouac, Barbara Ruiz, Eric Hachulla, Elisabeth Diot, Jean-Luc Cracowski, Kiet Tiev, Jean Sibilia, Luc Mouthon, Camille Frances, Zahir Amoura, Patrick Carpentier, Anne Cosnes, Olivier Meyer, Andre Kahan, Catherine Boileau, Gilles Chiocchia, Yannick Allanore.   

Abstract

OBJECTIVE: Accumulating evidence suggests that B cells are involved in systemic sclerosis (SSc). BANK1 has been reproducibly reported to be associated with diffuse cutaneous SSc (dcSSc). BLK encodes another B cell signal transducer, and a functional variant at the C8orf13-BLK locus has been found to be associated with SSc in Caucasians. However, no independent replication has been reported, and there are discrepancies in the genotype-phenotype correlation between these studies in Caucasians and another study performed in the Japanese population. Therefore, in a large cohort of French Caucasians and using a meta-analysis of the available data, this study was undertaken to determine whether the C8orf13-BLK locus is associated with SSc, and to assess the possibility of interaction between BLK and BANK1 in SSc.
METHODS: The C8orf13-BLK rs13277113 genotype was determined in 1,031 patients with SSc and 1,014 control subjects for whom BANK1 genotypes were available. Meta-analysis of the 3 available data sets (6,078 individuals) was also performed.
RESULTS: Minor allele frequencies for rs13277113 revealed an association restricted to the dcSSc subtype (P = 0.012, odds ratio [OR] 1.29) in the French sample. Meta-analysis of the combined Caucasian populations showed an association of this genotype with both SSc (P = 0.0013, OR 1.16, 95% confidence interval [95% CI] 1.06-1.26) and dcSSc (P = 0.0012, OR 1.23, 95% CI 1.08-1.39). Inclusion of the Japanese population confirmed the overall association with the disease, with the strongest association observed with dcSSc (P = 3.27 × 10⁻⁵, OR 1.27). Secondary analysis in the French sample revealed additive effects between C8orf13-BLK and BANK1, mainly in the dcSSc subset.
CONCLUSION: These results confirm C8orf13-BLK as an SSc risk locus. The strongest effects, and particularly additive effects, were observed in the interaction between C8orf13-BLK and BANK1 in the dcSSc subset.
Copyright © 2011 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21480188     DOI: 10.1002/art.30379

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  25 in total

Review 1.  Unraveling the genetic component of systemic sclerosis.

Authors:  José Ezequiel Martín; Lara Bossini-Castillo; Javier Martín
Journal:  Hum Genet       Date:  2012-01-05       Impact factor: 4.132

Review 2.  Genetic architectures of seropositive and seronegative rheumatic diseases.

Authors:  Yohei Kirino; Elaine F Remmers
Journal:  Nat Rev Rheumatol       Date:  2015-04-28       Impact factor: 20.543

Review 3.  Pathogenesis of Systemic Sclerosis.

Authors:  Debendra Pattanaik; Monica Brown; Bradley C Postlethwaite; Arnold E Postlethwaite
Journal:  Front Immunol       Date:  2015-06-08       Impact factor: 7.561

4.  Independent replication and meta analysis of association studies establish TNFSF4 as a susceptibility gene preferentially associated with the subset of anticentromere-positive patients with systemic sclerosis.

Authors:  Baptiste Coustet; Matthieu Bouaziz; Philippe Dieudé; Mickael Guedj; Lara Bossini-Castillo; Sandeep Agarwal; Timothy Radstake; Javier Martin; Pravitt Gourh; Muriel Elhai; Eugénie Koumakis; Jérôme Avouac; Barbara Ruiz; Maureen Mayes; Frank Arnett; Eric Hachulla; Elisabeth Diot; Jean-Luc Cracowski; Kiet Tiev; Jean Sibilia; Luc Mouthon; Camille Frances; Zahir Amoura; Patrick Carpentier; Anne Cosnes; Olivier Meyer; André Kahan; Catherine Boileau; Gilles Chiocchia; Yannick Allanore
Journal:  J Rheumatol       Date:  2012-03-15       Impact factor: 4.666

Review 5.  Genetics of systemic sclerosis.

Authors:  Lara Bossini-Castillo; Elena López-Isac; Maureen D Mayes; Javier Martín
Journal:  Semin Immunopathol       Date:  2015-06-02       Impact factor: 9.623

Review 6.  The genetics of scleroderma: looking into the postgenomic era.

Authors:  Maureen D Mayes
Journal:  Curr Opin Rheumatol       Date:  2012-11       Impact factor: 5.006

Review 7.  Unfolding the pathogenesis of scleroderma through genomics and epigenomics.

Authors:  Pei-Suen Tsou; Amr H Sawalha
Journal:  J Autoimmun       Date:  2017-05-16       Impact factor: 7.094

8.  A nonsynonymous SNP in BANK1 is associated with serum LDL cholesterol levels in three Korean populations.

Authors:  Kyung-Won Hong; Jieun Lyu; So Hyun Lee; Bo Youl Choi; Sung Soo Kim; Yeonjung Kim
Journal:  J Hum Genet       Date:  2015-01-22       Impact factor: 3.172

Review 9.  Genetics, Epigenetics, and Genomics of Systemic Sclerosis.

Authors:  Gloria Salazar; Maureen D Mayes
Journal:  Rheum Dis Clin North Am       Date:  2015-05-20       Impact factor: 2.670

10.  Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders.

Authors:  Frederick W Miller; Robert G Cooper; Jiří Vencovský; Lisa G Rider; Katalin Danko; Lucy R Wedderburn; Ingrid E Lundberg; Lauren M Pachman; Ann M Reed; Steven R Ytterberg; Leonid Padyukov; Albert Selva-O'Callaghan; Timothy R D J Radstake; David A Isenberg; Hector Chinoy; William E R Ollier; Terrance P O'Hanlon; Bo Peng; Annette Lee; Janine A Lamb; Wei Chen; Christopher I Amos; Peter K Gregersen
Journal:  Arthritis Rheum       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.